Skip to main content
. 2020 May 1;11:2150. doi: 10.1038/s41467-020-16044-8

Table 1.

Developmental efficiency of SCNT embryos derived from donor cells with Sfmbt2 miRNA KO or placenta-specific imprinted genes KO.

Genotype of donor cells KO allele N** No. of cultured embryos No. of cleaved embryos (%) No. of embryos transferred (ET) No. of recipient females No. of implantations (%/ET) No. of live pups born (%/ET) No. of placentas without pups (%/ET)
Wild type 3 167 152 (91.0) 101 4 48 (47.5) 3 (3.0) 4 (4.0)
Sfmbt2 KO m or p 6 382 364 (94.3) 234 12 97 (41.5) 6 (2.6) 4 (1.7)
Gab1 KO m 2 277 225 (81.2) 203 9 75 (36.9) 3 (1.5) 7 (3.4)
Sfmbt2 miRNA KO m 2 102 88 (86.3) 75 3 27 (36.0) 5 (6.7) 2 (2.7)
Sfmbt2 miRNA/Gab1 KO m/m 2 187 164 (87.7) 134 5 60 (44.8) 9 (6.7) 3 (2.2)
Slc38a4 KO* m 2 84 79 (94.0) 40 2 21 (52.5) 3 (7.5) 1 (2.5)
Wild type* 3 201 194 (96.5) 179 9 110 (61.5) 15 (8.4) 3 (1.7)

*Embryos injected with Kdm4d mRNA instead of treatment with trichostatin A/latrunculin A. Data for the wild type are those reported by Matoba et al.16.

**Number of experimental replicates.